Kabir is based in Squamish, BC, and has over a decade of experience in health economics and outcomes research (HEOR) and consulting. In his previous roles, Kabir led sales and the execution of global health technology assessment (HTA) submissions, as well as early strategy for high-value assets specializing in projects with complex cross-functional dependencies and implementing novel methods. He has led multidisciplinary and multinational teams in supporting major pharmaceutical companies to bring products to launch, leading to positive reimbursement decisions in numerous countries including the US, UK, Canada, and France. His experience spans several therapeutic areas including, but not limited to, oncology, cardiology, dermatology, neurology, and endocrinology.